Article
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma.
Journal for ImmunoTherapy of Cancer
(2020)
Disciplines
Publication Date
May 1, 2020
DOI
10.1136/JITC-2020-000773
Citation Information
Brendan Curti, Marka Crittenden, Steven K Seung, Christopher B Fountain, et al.. "Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma." Journal for ImmunoTherapy of Cancer Vol. 8 Iss. 1 (2020) p. 1177 Available at: http://works.bepress.com/walter-urba/285/